Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Pummer

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
The Journal of Urology|December 20, 2011
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkersShahrokh F Shariat, Thomas F Chromecki, Eugene K Cha, et al.
World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
European Urology|October 7, 2011
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
BJU International|June 26, 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
World Journal of Urology|October 20, 2011
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomyThomas F Chromecki, Julian Mauermann, Eugene K Cha, et al.
World Journal of Urology|April 19, 2011
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomyThomas F Chromecki, Behfar Ehdaie, Giacomo Novara, et al.
European Urology|July 16, 2013
Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision toolLuis A Kluth, Firas Abdollah, Evanguelos Xylinas, et al.
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
The Journal of Urology|December 20, 2011
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkersShahrokh F Shariat, Thomas F Chromecki, Eugene K Cha, et al.
World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
European Urology|October 7, 2011
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
BJU International|June 26, 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
World Journal of Urology|October 20, 2011
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomyThomas F Chromecki, Julian Mauermann, Eugene K Cha, et al.
World Journal of Urology|April 19, 2011
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomyThomas F Chromecki, Behfar Ehdaie, Giacomo Novara, et al.
European Urology|July 16, 2013
Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision toolLuis A Kluth, Firas Abdollah, Evanguelos Xylinas, et al.
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
Pageof 11